Vivus Names Fischer CEO as Zook Resigns for Health Reasons
This article is for subscribers only.
Vivus Inc., the obesity-drug maker that overturned its board and management in July after a proxy fight with its largest shareholder, said new Chief Executive Officer Tony Zook has resigned because of health reasons.
Seth H. Z. Fischer, formerly with Johnson & Johnson, will replace Zook immediately, the Mountain View, California-based company said today in a statement. Vivus cited “recurring issues associated with a previously diagnosed medical condition” for Zook’s departure.